$2.81
1.44% yesterday
Nasdaq, Nov 25, 10:16 pm CET
ISIN
US38246G1085
Symbol
GDRX

GoodRx Holdings Stock price

$2.81
-0.96 25.46% 1M
-0.93 24.87% 6M
-1.84 39.57% YTD
-2.08 42.54% 1Y
-1.88 40.09% 3Y
-35.76 92.71% 5Y
-30.19 91.48% 10Y
-30.19 91.48% 20Y
Nasdaq, Closing price Tue, Nov 25 2025
+0.04 1.44%

Key metrics

Basic
Market capitalization
$940.2m
Enterprise Value
$1.2b
Net debt
$215.6m
Cash
$273.5m
Shares outstanding
341.2m
Valuation (TTM | estimate)
P/E
30.8 | 7.3
P/S
1.2 | 1.2
EV/Sales
1.4 | 1.4
EV/FCF
11.0
P/B
1.6
Financial Health
Equity Ratio
52.2%
Return on Equity
2.3%
ROCE
7.3%
ROIC
5.1%
Debt/Equity
0.8
Financials (TTM | estimate)
Revenue
$800.7m | $813.9m
EBITDA
$164.2m | $271.2m
EBIT
$83.0m | $205.8m
Net Income
$31.8m | $129.8m
Free Cash Flow
$104.9m
Growth (TTM | estimate)
Revenue
1.3% | 2.7%
EBITDA
32.6% | 100.3%
EBIT
179.7% | 212.5%
Net Income
295.7% | 691.8%
Free Cash Flow
18.6%
Margin (TTM | estimate)
Gross
93.5%
EBITDA
20.5% | 33.3%
EBIT
10.4%
Net
4.0% | 15.9%
Free Cash Flow
13.1%
More
EPS
$0.1
FCF per Share
$0.3
Short interest
8.1%
Employees
738
Rev per Employee
$1.1m
Show more

Is GoodRx Holdings a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,053 stocks worldwide.

GoodRx Holdings Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a GoodRx Holdings forecast:

13x Buy
62%
7x Hold
33%
1x Sell
5%

Analyst Opinions

21 Analysts have issued a GoodRx Holdings forecast:

Buy
62%
Hold
33%
Sell
5%

Financial data from GoodRx Holdings

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
801 801
1% 1%
100%
- Direct Costs 52 52
3% 3%
7%
748 748
1% 1%
93%
- Selling and Administrative Expenses 460 460
6% 6%
57%
- Research and Development Expense 124 124
0% 0%
15%
164 164
33% 33%
21%
- Depreciation and Amortization 81 81
14% 14%
10%
EBIT (Operating Income) EBIT 83 83
180% 180%
10%
Net Profit 32 32
296% 296%
4%

In millions USD.

Don't miss a Thing! We will send you all news about GoodRx Holdings directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

GoodRx Holdings Stock News

Neutral
Business Wire
9 days ago
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more widely available. First, the launch of GoodRx for Weight Loss, a telemedicine subscription that connects consumers to licensed healthcare providers for affordable weight management treatment. Seco...
Neutral
Seeking Alpha
20 days ago
GoodRx Holdings, Inc. ( GDRX ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Aubrey Reynolds - Director of Investor Relations Wendy Barnes - President, CEO & Director Christopher McGinnis - CFO & Treasurer Conference Call Participants Michael Cherny - Leerink Partners LLC, Research Division Daniel Grosslight - Citigroup Inc., Research Division Lisa Gill - JPMorgan Chas...
Positive
PYMNTS
20 days ago
GoodRx CEO Wendy Barnes sees a “profound transformation” happening in prescription drug pricing. The catalyst, Barnes said during an earnings call Wednesday (Nov. 3), is the pending launch of TrumpRx, the planned government-run prescription drug website.
More GoodRx Holdings News

Company Profile

GoodRx Holdings, Inc. operates a consumer-focused digital healthcare platform. The firm offers information and tools to help consumers compare prices for prescription drugs. It operates applications and websites that provide prices and discounts at local and mail-order pharmacies. The company was founded in September 2015 and is headquartered in Santa Monica, CA.

Head office United States
CEO Wendy Barnes
Employees 738
Founded 2015
Website investors.goodrx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today